Atom’s lingdolinurad (ABP-671), a URAT1 inhibitor, is in late stage global clinical trials for chronic gout and ABP-745, an anti-inflammatory drug, is in multi-country Phase 2 trials for acute gout ...

Despite the mechanisms that made it a “biologically plausible” candidate, the study found that participants who took the drug ...

The drug colchicine may reduce cardiovascular outcomes among patients with gout, based on a range of retrospective data that ...

In patients with gout, a novel prediction tool that relies on weight and creatinine clearance successfully identified the ...

The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...

MADRID -- The high-dose inactivated influenza vaccine may reduce older people's risk of hospitalization for flu or pneumonia more than a standard-dose shot, according to two large open-label, ...